Networth Advisors, LLC

Position in EXEL — Exelixis, Inc.

CIK 2099019 CANONSBURG, PA

Position in EXEL

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$3,699

New position

Shares Held

68

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#699

of 751 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Networth Advisors, LLC holds $191,764 across 5 Biotechnology names. EXEL ranks #4 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABCL	AbCellera Biologics Inc.	22,526	$176,829
2	INCY	Incyte Corp	54	$6,121
3	RPRX	Royalty Pharma plc	69	$3,868
4	EXEL	Exelixis, Inc. This page	68	$3,699
5	REGN	Regeneron Pharmaceuticals, Inc.	2	$1,247

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,699	68	—	Shares	Sole	2026-07-22
No filing history on record for this holder in this stock.